PledPharma AB | Income Statement
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
-
-
-
13,585.00
Cost of Goods Sold (COGS) incl. D&A
26,371.00
48,799.00
2.00
-
26,521.00
Gross Income
26,371.00
48,799.00
2.00
-
12,936.00
SG&A Expense
-
-
44,276.00
39,032.00
-
EBIT
26,371.00
48,799.00
44,278.00
-
87,133.00
Unusual Expense
32.00
19.00
-
-
-
Non Operating Income/Expense
286.00
86.00
240.00
669.00
964.00
Pretax Income
25,549.00
48,420.00
43,836.00
38,223.00
87,935.00
Consolidated Net Income
25,549.00
48,420.00
43,836.00
38,223.00
87,935.00
Net Income
25,549.00
48,420.00
43,836.00
38,223.00
87,935.00
Net Income After Extraordinaries
25,549.00
48,420.00
43,836.00
38,223.00
87,935.00
Net Income Available to Common
25,549.00
48,420.00
43,836.00
38,223.00
87,935.00
EPS (Basic)
1.12
2.10
1.50
1.30
1.80
Basic Shares Outstanding
22,677.70
22,649.80
28,373.10
29,722.20
48,666.70
EPS (Diluted)
1.13
2.10
1.54
1.29
1.81
Diluted Shares Outstanding
22,677.70
23,049.80
28,373.10
29,722.20
48,666.70
EBITDA
26,369.00
48,797.00
44,276.00
39,032.00
87,133.00
Other Operating Expense
-
-
-
-
74,197.00
Non-Operating Interest Income
568.00
312.00
202.00
140.00
162.00
About PledPharma AB
View Profile
